This workshop (free of charge) will gather representatives from photonics companies, med-tech companies, end-users and researchers interested in commercialisation and a number of experts, to discuss and network around issues related to the business development of photonics companies addressing the global healthcare market.
Experts confirmed (one more to come from the UK)
- Prof. Juergen Popp, Leibniz Institute of Photonic Technology Jena, Institute of Physical Chemistry & Abbe-Center of Photonics, Friedrich-Schiller University and InfectoGnostics Research Campus, Jena, Germany. J. Popp is also WG3 Chair of Photonics21.
- Iris Öhrn, advisor at Business Region Gothenburg, MBA Biotechnology, member of the Jury of top experts that pick market-creating innovations for EU funding under the SME Instrument programme.
- Dr. Thierry Robin, TEMATYS, Partner, Paris, France. TEMATYS provides an advanced marketing expertise dedicated to photonic products ands its application markets.
- Dr. Dirk Voelkel, CTO GE Healthcare Life Sciences AB, Uppsala, Sweden. Collaboration with large healthcare companies.
- Dr. Ruth Houbertz, CEO & Manag. Dir. of Multiphoton Optics GmbH, Würzburg, Germany. Innovation/best teams/tech. transfer.
- Edward Schneider, CEO of Quan Fund, Geneva, Switzerland. VC financing for KETs-based products.
- Dr. Raoul Stubbe, Business Coach at Stockholm Innovation and Growth (STING) and co-founder of Single Technologies AB, Stockholm, Sweden.
- Dr. Ian McCabe, NCLA, School of Physics, NUI Galway, Ireland. Value-Chain Analysis techniques.